CytomX Therapeutics Inc. (CTMX)
NASDAQ: CTMX
· Real-Time Price · USD
2.15
-0.17 (-7.33%)
At close: Jun 23, 2025, 3:59 PM
2.16
0.23%
After-hours: Jun 23, 2025, 07:59 PM EDT
-7.33% (1D)
| Bid | 2.12 |
| Market Cap | 339.51M |
| Revenue (ttm) | 147.56M |
| Net Income (ttm) | 41.6M |
| EPS (ttm) | 0.48 |
| PE Ratio (ttm) | 4.49 |
| Forward PE | -5.67 |
| Analyst | Buy |
| Ask | 2.2 |
| Volume | 2,307,520 |
| Avg. Volume (20D) | 4,984,604 |
| Open | 2.31 |
| Previous Close | 2.32 |
| Day's Range | 2.10 - 2.32 |
| 52-Week Range | 0.40 - 3.10 |
| Beta | 2.12 |
About CTMX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTMX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CTMX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
CytomX Therapeutics Inc. is scheduled to release its earnings on Aug 7, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+4.93%
CytomX Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
1 month ago
+129.43%
CytomX Therapeutics shares are trading higher. The company announced a $100 million offering of 76.9 million shares at $1.30 per share.
